Abstract. Fibroblasts have cell surface sites that mediate assembly of plasma and cellular fibronectin into the extracellular matrix. Cell adhesion to fibronectin can be mediated by the interaction of an integrin (oL5/3~) with the Arg-Gly-Asp-Ser (RGDS)-containing cell adhesion region of fibronectin. We have attempted to elucidate the role of the otsfll fibronectin receptor in assembly of fibronectin in matrices. Rat monoclonal antibody mAb 13, which recognizes the integrin fll subunit, completely blocked binding and matrix assembly of 125I-fibronectin as well as binding of the 1251-70-kD amino-terminal fragment of fibronectin (70 kD) to fibroblast cell layers. Fab fragments of the anti-/~ antibody were also inhibitory. Antibody mAb 16, which recognizes the integrin ors subunit, partially blocked binding of 125I-fibronectin and 12q-70-kD.
ate assembly of plasma and cellular fibronectin into the extracellular matrix. Cell adhesion to fibronectin can be mediated by the interaction of an integrin (oL5/3~) with the Arg-Gly-Asp-Ser (RGDS)-containing cell adhesion region of fibronectin. We have attempted to elucidate the role of the otsfll fibronectin receptor in assembly of fibronectin in matrices. Rat monoclonal antibody mAb 13, which recognizes the integrin fll subunit, completely blocked binding and matrix assembly of 125I-fibronectin as well as binding of the 1251-70-kD amino-terminal fragment of fibronectin (70 kD) to fibroblast cell layers. Fab fragments of the anti-/~ antibody were also inhibitory. Antibody mAb 16, which recognizes the integrin ors subunit, partially blocked binding of 125I-fibronectin and 12q-70-kD.
When cell layers were coincubated with fluoresceinated fibronectin and either anti-13~ or anti-us, anti-131 was a more effective inhibitor than anti-o~s of binding of labeled fibronectin to the cell layer. Inhibition of ~2q-fibmnectin binding by anti-/31 IgG occurred within 20 min. Inhibition of 125I-fibronectin binding by anti-/3t Fab fragments or IgG could not be overcome with increasing concentrations of fibronectin, suggesting that anti-131 and exogenous fibronectin may not compete for the same binding site. No/31-containing integrin bound to immobilized 70 kD. These data indicate that the/31 subunit plays an important role in binding and assembly of exogenous fibronectin, perhaps by participation in the organization, regeneration, or cycling of the assembly site rather than by a direct interaction with fibronectin.
F
IBRONECTIN is a dimeric glycoprotein consisting of two similar 250-kD disulfide-bonded subunits. Fibronectin exists in soluble and insoluble forms. Soluble protameric fibronectin is found at high concentrations in plasma and other bodily fluids and in the conditioned media of cultured cells. Insoluble fibronectin consists of high molecular weight disulfide-bonded multimers organized into an extracellular fibrillar matrix (Mosher, 1980 (Mosher, , 1984 Hynes, 1981; Mosher and McKeown-Longo, 1985; Hedman and Vaheri, 1989; Yamada, 1989) .
Insoluble fibronectin mediates cell attachment, provides a substrate for cell migration during embryogenesis and wound healing, and thus is considered the primary functional form of the protein (Ruoslahti, 1988; Thiery et al., 1989; Colvin, 1989) . A crucial cell attachment site has been localized to a specific tetrapeptide sequence, Arg-Gly-Asp-Ser (RGDS), found in the central region of each fibronectin subunit (Pierschbacher and Ruoslahti, 1984; Yamada, 1989) . Cell attachment to fibronectin is mediated in part by the interaction of the RGDS site with a specific cell surface fibronectin receptor (txs~), a member of the noncovalent heterodimer integrin receptor group (Pytela et al., 1985; Hemler et al., 1987; Hynes, 1987; Takada et al., 1987; Ruoslahti, 1988) .
The mechanism by which fibronectin is incorporated into the extracellular matrix is unclear. One proposed mechanism involves a disulfde exchange reaction between the aminoterminal portion of different fibronectin molecules (McKeown-Longo and Mosher, 1984) . Transglutaminase-mediated cross-linking also promotes insolubilization Mosher, 1988, 1989) . Fibronectin insolubilization and assembly appear to occur at the cell surface. Dimeric and multimeric fibronectin have been localized at the cell surface using metabolic and cell surface-labeling techniques (Hynes and Destree, 1977; Keski-Oja et al., 1977; Choi and Hynes, 1979) . In vitro and in vivo studies have shown that cell surface associated fibronectin consists of both endogenously synthesized cellular fibronectin and circulating plasma fibronectin (Oh et al., 1981; Sekiguchi et al., 1986) .
Fibroblast monolayers bind soluble iodinated plasma and cellular fibronectin in a specific and saturable manner (McKeown-Longo and Mosher, 1983; Allio and McKeownLongo, 1988) . Initially, fibronectin is reversibly bound and soluble in 1% deoxycholate but with longer incubation times fibronectin forms deoxycholate insoluble disulfide-bonded multimers. Pulse-chase and saturation kinetic experiments indicate that the deoxycholate soluble pool is the precursor of the insoluble pool (McKeown-Longo and Mosher, 1983; Barry and Mosher, 1988) . The binding data are further supported by microscopic studies which show that fluoresceinand gold-labeled fibronectin localize initially in clusters along the edge of the cell that at later times become rearranged into long fibrillar structures along the cell surface (McKeown-Longo and Mosher, 1983; Pesciotta-Peters and Mosher, 1987) . ~25I-fibronectin does not bind specifically to isolated matrices and does not form disulfide-bonded or transglutaminase cross-linked multimers in the absence of cells (McKeown-Longo and Mosher, 1983; Barry and Mosher, 1988) .
The importance of cells in mediation of fibronectin matrix assembly is supported by the observation that transforming growth factor-beta and agents which modulate intracellular cAMP levels influence fibronectin matrix assembly activity (Allen-Hoffmann and Mosher, 1987; Allen-Hoffmann et al., 1988) . HT1080 fibrosarcoma cells bind and assemble exogenous fibronectin into a matrix only after treatment with dexamethasone (McKeown-Longo and Etzler, 1987) .
Three experimental results suggest that exogenous soluble fibronectin binding to cell monolayers is mediated by the fibronectin amino-terminal region rather than the RGDS cell attachment site. First, 70-and 27-kD amino-terminal fragments, lacking the RGDS cell attachment site, bind to fibroblast monolayers and compete with exogenous fibronectin for binding Quade and McDonald, 1988) . Second, the 70-kD amino-terminal fragment (70 kD) and a monoclonal antibody to the fibronectin aminoterminal region block endogenously synthesized fibronectin matrix assembly (McDonald et al., 1987) . Third, 3T3 cells, infected with a retroviral expression vector containing cDNA that encodes for fibronectin lacking the amino-terminal half, synthesize and secrete recombinant truncated fibronectins referred to as deminectins. Deminectin homodimers are not incorporated into the matrix (Schwarzbauer et al., 1987) . Exogenous fibronectin binding and matrix assembly mediated by the amino-terminal region rather than the RGDS-containing cell adhesion domain led to the proposal of a distinct "matrix assembly receptor" on substrate attached cells (McKeown-Longo and Mosher, 1983 .
There are also data that suggest involvement of both the fibronectin cell adhesion domain and the t~/~) fibronectin cell adhesion receptor in fibronectin matrix assembly. A 105-kD RGDS containing cell binding fragment and a monoclonal antibody that recognizes the fibronectin cell attachment site block matrix assembly of endogenously synthesized fibronectin (McDonald et al., 1987) .~ Rat monoclonal antibodies mAb 16 and mAb 13, which bind to the ct5 and ~ subunits, respectively, of the human fibroblast fibronectin receptor complex, inhibit fibronectin matrix formation when incubated with freshly seeded human WI38 fibroblast cultures .
In this paper, we have examined the effect of monoclonal antibodies specific for the integrin ct5 subunit (mAb 16) and the integrin/~ subunit (mAb 13) on exogenous fibronectin and 70-kD binding to fibroblast monolayers in short-term as-1. McKeown-Longo and Mosher (1985) reported that cell adhesion fragments up to 0.25 #M did not inhibit binding of exogenous fibronectin. We find that higher concentrations similar to those used by McDonald et al. (1987) are inhibitory (Fogerty, E J., and D. E Mosher, unpublished data).
says. We wished to learn if these antibodies block binding and assembly of exogenous fibronectin, about the kinetics of the inhibition, and especially whether the antibodies block binding of the 70-kD fragment. These studies indicate that the/31 protein plays an important although unclear role in matrix assembly.
Materials and Methods

Materials
Human neonatal foreskin fibroblasts were from a locally established strain (Dr. Lynn Allen-Hoffmann, University of Wisconsin) and were studied between passages 10 and 20. Human osteosareoma cells were from the American Type Culture Collection (Rockville, MD). Cathepsin D, cycloheximide, soybean trypsin inhibitor, chymotrypsin (type II), PMSF, BSA (fraction V), lactoperoxidase (from bovine milk), deoxycholate, cyanogen bromide, gelatin (from swine skin), and Sepharose CL-4B-200 were from Sigma Chemical Co. (St. Louis, MO). Trypsin was from ICN Biomedicals, Inc. (Irvine, CA). Octyl-/~-D-thioglucopyranoside and protein A-agarose were purchased from Calbiochem-Behring Corp. (La Jolla, CA). HeparinSepharose was from Pharmacia (Piscataway, NJ). Carder-free I~iodine and Na2S~Cr04 were from Dupont (Hoffmann Estates, IL). Gelatin-Sepharose was pro'pared in this lab following a published procedure (Cuatrecasas, 1970) . Acrylamide/bis-Acrylamide (37.5:1 solution) was purchased from American Research Products Corp. (Solon, OH). Reagents for SDS-PAGE were from Bio-Rad Laboratories (Richmond, CA).
Antibodies
MAb 16 and mAb 13 have been previously described Matsuyama et al., 1989) . Rabbit polyclonal anti-~5~l was a generous gift from Dr. Erkki Ruoslahti (La Jolla Cancer Research Foundation, La Jolla, CA). Mouse monoclonal antibody J143 was a gift from Dr. Lloyd J. Old (Memorial Sloan-Kettering Cancer Center, New York) and is specific for the integrin t~3 subunit Kantor et al., 1987) . Mouse monoclonal antibody PIB5 was a gift from Drs. Elizabeth Wayner and William Carter (Fred Hutchinson Cancer Research Center, Seattle, WA) . Monoclonal antibody P1B5 is specifc for integrin ot3fll and was previously shown to block tx3fll function (Wayner and Carter, 1987; Takada et al., 1988) . Mouse monoclonal antibodies LM142 and LM609 were gifts from Dr. David A. Cheresh (Research Institute of Scripps Clinic, La Jolla, CA). Monoclonal antibody LM142 is directed against the vitronectin receptor tx subunit (Cheresh and Harper, 1987) . Monoclonal antibody LM609 is c~v/~3 complex specific and was previously shown to block art3 function (Cheresh and Spiro, 1987) .
Experimental Procedures
Cell Culture. Human foreskin fibroblasts were cultured in 50% Ham's F-12 (Gibco Laboratories, Grand Island, NY), 50 % Dulbecco's modified Eagle's medium (Gibco Laboratories), supplemented with 10% fetal calf serum (Hazleton, Denver, PA). Human osteosarcoma MG-63 cells were cultured in Eagle's minimum essential media (Gibco Laboratories) supplemented with 5% fetal calf serum.
Fibroneeffn and lqbroneetin Fragments. Human plasma fibronectin was purified as previously described from a fibronectin-and fibrinogen-rich by-product of Factor VRI production (Mosher and Johnson, 1983) . The 70-kD amino-terminal, gelatin-binding fragment of fibronectin (70 kD) was purified from cathepsin D digests of fibronectin as previously described with the following modifications. Digestion was allowed to proceed for 3 h at 37°C and an additional 2 h at 22°C. The pH of the digest was immediately raised to 7.4 with the addition of 0.5 M Tris, and the neutralized digest was directly applied to a gelatinSepharose column. After elution with 3 M guanidine hydrochloride, 70-kD fragment was separated from a contaminating 40-kD gelatin-binding breakdown product on a G-100 gel filtration column run in TBS (150 mM NaCI/ 10 mM Tris, pH 7.4). Purity of fragments was assessed by SDS-PAGE (Laemmli, 1970) . Fragment aliquots were stored at -70"C.
Iodination of Fibronectin and 70 kD. Iodination of fibronectin and 70 kD was performed using the chloramine T method as previously described Mosher, 1983, 1985) . The specific activities of 12~I-fibronectin and 1251-70 kD were typically ~350 #Ci/mg. Purity of labeled proteins was assessed by SDS-PAGE with and without reduction followed by autoradiography.
12Sl-Fibronectin and IZ~l-70 kD Binding Assays. Human foreskin fibroblasts were seeded 6-8 x 104 cells per 2-cm 2 well (24-well plates; Becton Dickinson Labware, Lincoln Park, NJ) and were used in binding assays 2--4 d after seeding when the cells reached confluency as assessed by phase microscopy. Medium (0.5 ml) containing 0.2% BSA, radioligand, and sometimes unlabeled ligand and/or antibody was added to the cell layers and incubated at 37"C for the indicated times. Free ligand was separated from bound by removing the binding mix and washing the cell layers thrice with cold PBS (150 mM NaCI/20 mM phosphate, pH 7.4). Then ceU layers were either solubilized in 1 N NaOH to determine the total amount of labeled ligand associated with the cell layer or separated into fractions soluble and insoluble in 1% deoxycholate (Pool I/II assay) as previously described (McKcown-Longo and Mosher, 1983) . In long-term (6 h) binding assays, cycloheximide (10 #g/ml), was added to eliminate possible effects of endogenously synthesized fibronectin.
Cell Adhesion Assay. Cell adhesion assays were performed using a method similar to that of Wayner and Carter, (1987) . Microtiter 96-well polystyrene plates (model 3596; Costar, Cambridge, MA) were coated with fibronectin or heat-denatured BSA (200/~1 protein solution in PBS per well, 5/~g protein/ml). Plates were coated for 1.5-4.5 h at 37°C and then blocked with 200/~1 of 1% heat denatured BSA in PBS for 1-2 h at 37°C. Plates were washed with PBS several times after blocking in BSA.
Fibroblasts in 75-cm 2 dishes (Becton Dickinson Labware) were labeled with Na~SlCrO4 (50 t~Ci/mi) for 2-4 h at 37°C in medium. Ceils were released by incubating for 5 rain at 370C in a mixture of 2 ml trypsin/PBS (0.05% wt/voi) and 2 ml EDTA/PBS (0.02% wt/vol). Trypsinization was stopped with the addition of 4 ml medium containing 10% FCS. The cells were pelleted and then resuspended in Ham's F-12 containing 0.2% BSA.
Suspended cells (0.8-1.3 x 10 s cells/ml) were incubated 30 min at room temperature with antibody or media alone. Aliquots (0.2 ml) of each incubation mixture (•1.6-2.5 x 104 cells) were pipetted into coated microtiter wells, and cells were allowed to adhere to the fibronectin or BSA coated surface for 15-30 min at 37°C. Nonadherent cells were removed by washing with PBS. Adherent cells were dissolved in 1 N NaOH and quantitated in a gamma counter. and IgG. Fluoresceihated fibronectin (FITC-fibronectin) was prepared as previously described (McKeown-Longo and Mosher, 1983) . Fibroblasts were seeded onto 13-ram glass coverslips (No. 2; Ernest Fullam, Inc., Schenectady, NY) placed in 2-cm 2 wells at 1 x 10 ~ cells per well, and allowed to attach overnight. The next day, serum-containing media was replaced with 0.5 mi of Ham's F-12 medium containing 0.2% BSA and 20/zg/ml FITC-fibronectin either alone or supplemented with 5 ~g/ml anti-/31 or anti-ors IgG. Cell layers were incubated for 60 min at 370C, then rinsed three times with PBS, and fixed for 30 min at room temperature in 0.1 M phosphate buffer, pH 7.4, containing 3.5 % paraformaldehyde. The distribution of integrin ors and/~1 subunits in cells incubated with anti-us and -/~l IgGs was visualized by immunofluorescence. After fixation, cells that had been incubated with FITC-fibronectin plus antibody were rinsed and then incubated 45 min at room temperature with a 1:16 dilution of rhodamine conjugated rabbit anti-rat IgG (Sigma Chemical Co.) in 1% BSA/PBS. The distribution of integrin ors and ~ subunits in cells not treated with antibodies was examined using cell layers that had been previously incubated with FITCfibronectin alone. These cell layers were incubated 60 rain after fixation with anti-~s or anti-/3t (5 #g/ml) in PBS containing 1% BSA followed by a 45-min incubation with the rhodamine conjugated rabbit anti-rat IgG. Coverslips were rinsed with PBS and mounted on glass slides in glycerolgelatin (Sigma Chemical Co.). Slides were viewed and photographed on a Nikon microscope equipped with epifluorescence and phase contrast. Cells were photographed using Ektachrome 400 film (Kodak, Rochester, NY).
Incorporation of Fluoresceinated Fibronectin into Cell Layers and Localization of
Surface Labeling and Extraction of Cells. Fibroblasts grown to
confuence in 75-cm 2 dishes were detached with 1 mM EDTA in PBS for 30-60 rain and collected by centrifugation. Cells were washed once with PBS, and resuspended to 1.0 x 10 s cells/ml in PBS with 1 mM MgCI2. All subsequent steps were done at 4°C. The suspended cells were radiolabeled according to the procedure of Lebien et al. (1982) using 1 mCi 12SI-sodium iodide and 0.2 mg/ml of lactoperoxidase per l0 s cells. Cells were lysed by adding 1 ml lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCI, 50 mM octyl-/~-o-thioglucopyranoside, 1 mM MgC12, 1 mM CaC12, 1 mM MnCI2, 3 mM PMSF) and incubating 30 rain on ice. Detergent-insoluble material was removed by centrifugation at 27000 g for 30 min.
Affinity Chromatography. The c~s~l fibronectin cell adhesion receptor was isolated following the methods of Pytela et al. (1985 Pytela et al. ( , 1987 . The 120-kD chymotryptic cell binding fragment of fibronectin was prepared as previously described . Briefly, 50 mg of fibronectin was diluted to a final concentration of 2 mg/ml in 50 mM Tris, pH Z4, containing 1 mM CaC12. Fibronectin was digested 75 rain at 37°C with chymotrypsin (type II; Sigma Chemical Co.) at a final concentration of 20 /~g/ml. The reaction was stopped with the addition of PMSF (final concentration of 2 mM) and soybean trypsin inhibitor (final concentration of 200 #g/ml). The 120-kD fragment was purified by gelatin-Sepharose and heparin-Sepharose chromatography. Approximately 9 mg of the 120-kD fragment was coupled to 25 ml of CNBr-activated Sepharose (Cuatrecasas, 1970) . 70 kD was prepared as described above, and "-25 mg was coupled to 60 ml of CNBr-activated Sepharose. Polyclonal rabbit antibodies to 70 kD were passed over the column and recovered with 0.2 M glycine, pH 2.3, to verify that 70 kD had coupled to Sepharose.
Batch adsorption was carried out by mixing 1 ml of the iodinated cell lysate with 3 ml of 120-kD Sepharose or 2.5 ml of 70-kD Sepharose overnight at 4°C. The slurries were then poured into columns and allowed to settle and equilibrate to room temperature. The unbound material was collected, and the column beds were then washed with 25 mM octyl-/3-D-thioglucopyranoside in 150 mM NaC1/50 mM Tris, pH 7.4. Bound material was eluted with 10 mM EDTA in 25 mM octyl-/3-D-thioglucopyranoside/150 mM NaCI/50 mM Tris, pH 7.4.70-kD Sepharose was further eluted with 0.2 M glycine, pH 2.3. Unbound and bound fractions were subjected to immunoprecipitation and analyzed by SDS-PAGE and autoradiography.
Imraunoprecipitatlons. Immunoprecipitations were carried out as described (Kessler, 1981; Harlow and Lane, 1988) . Samples were precleared by incubating with 25 #g/ml preimmune rabbit IgG for 60 min at 4°C followed by a 60-min incubation with protein A-agarose. The supernatant was then removed to a new tube and incubated overnight with 50-100/zg/ml rabbit anti-cts/3t IgG. The next day, antigen-antibody complexes were precipitated by incubating 60 min with protein A-agarose. The resin was allowed to settle, supernatant was removed, and resin was washed five times with 1 ml of 1% Triton X-100/PBS. Antigen-antibody complexes were eluted with 10% SDS in 9 M urea and subjected to SDS-PAGE.
Gel Electrophoresis. SDS-PAGE was performed using 8% separating and 3.3% stacking gels (Laemmli, 1970) . 14C-methylated protein standards (Amersham Corp., Arlington Heights, IL) were myosin (Mr 200,000), phosphorylase-b (Mr 92,500), bovine serum albumin (Mr 69,000), ovalbumin (Mr 46,000), carbonic anhydrase (Mr 30,000). Dried gels were exposed to Kodak XAR-2 film for 4 d. (Fig. 1 A) . Approximately 40-60% of the 1251-fibronectin and 1251-70 kD specific binding was blocked with 2.0/zg/ml IgG. Higher concentrations, up to 20/~g/ml, did not inhibit more. Anti-as inhibited initial fibroblast attachment to fibronectin with a dose response similar to that observed for inhibition of binding (Fig. 1 A) .
Results
Effect of Monoclonal Antibodies
In contrast, anti-~ completely blocked binding of both 125I-fibronectin and t2sI-70 kD to cell layers and blocked initial cell attachment to a fibronectin substratum (Fig. 1 B) . Similar inhibition of l:sI-fibronectin and 1251-70 kD binding by anti-/31 and anti-a~ was seen with MG-63 osteosarcoma cells (data not shown).
We examined what effect these antibodies had on exogenous FITC-fibronectin binding to cultured fibroblast monolayers (Fig. 2) In the phase-contrast micrographs and in routine observation of cells by phase microscopy during the various binding assays, anti-/~i and anti-u5 IgGs did not cause gross changes in cell morphology during a 60-min incubation.
Two monoclonal antibodies specific for a3fl~, J143 and P1B5, failed to block binding of fibronectin or 70-kD fragment to cell layers (data not shown). Monoclonal antibodies to av (LM142) and av~3 (LM609) also were not inhibitory (data not shown). These results suggested that neither the a3~3~ nor the Otvf33 integrins were involved in binding the amino-terminal region of fibronectin and provided further proof that the observed inhibition of binding by anti-as and anti-fl~ was due to specific interactions.
Time Course of Inhibition of Binding of 12~I-Fibronectin by Anti-~1 IgG
To learn whether inhibition of exogenous fibronectin binding by anti-/~ is immediate, fibroblast monolayers were incubated with ~25I-fibronectin in the presence or absence of anti-/~ or excess fibronectin for varying times (Fig. 3) . Inhibition of binding was demonstrable 20 rain after the addition of radioligand and IgG. In contrast, inhibition by excess fibronectin occurred at 3 min.
in the absence of antibody. Nonspecific background cell adhesion to albumin-coated wells was negligible (<1.0%). Each point represents the average of triplicate determinations, and error bars indicate the standard deviation. Figure 2 . Effect of anti-c~5 and -fl~ IgGs on binding of FITC-fibronectin to cell layers and on the distribution of the fibronectin receptor subunits. The effect of anti-c~5 IgG on the binding of FITC-fibronectin was visualized by fluorescence microscopy after a 60-min incubation of cell layers with 20 #g/ml FITC-fibronectin alone (B) or in the presence of 5 /~g/ml anti-us IgG (A). The cell layers were fixed and the distribution of c~5 on cells exposed to anti-c~5 during the 1-h incubation (E) or on cells reacted with anti-c~5 after fixation (F) was determined with a rhodamine-labeled second antibody. Corresponding phase fields are shown in (/) and (J). The effect of anti-/~t IgG on the binding of FITC-fibronectin was visualized after a 60-min incubation of cell layers with 20/~g/ml FITC-fibronectin alone (D) or in the presence of 5/~g/ml anti-/~ IgG (C). The cell layers were fixed and distribution of ~ on cells exposed to anti-/3~ IgG during the 1-h incubation (G) or on cells reacted with anti-/3~ IgG after fixation (H) was determined with a rhodamine-labeled second antibody. Corresponding phase fields are shown in (K) and (L). Arrowheads mark places that contain FITC-fibronectin (D) but lack 131 staining (H). Bar, 1 #m.
Effect of Anti-~, Fab Fragments on Binding of ~zJl-l~bronectin and x2q-70 kD to Fibroblast Cell Layers and on Fibroblast Attachment to a Fibronectin Substratum
Monovalent Fab fragments were tested to rule out the possibility that inhibition of fibronectin and 70 kD binding at 37°C by anti-/~ IgG was the indirect result of changes in membrane organization associated with receptor clustering induced by the bivalent IgG. A longer incubation time (6 h) was used so that inhibition of t25I-fibronectin incorporation into deoxycholate-insoluble matrix (pool II) could be quantified. Anti-/3~ Fabs blocked ~2~I-fibronectin and t251-70 kD binding to fibroblast cell layers and ~25I-fibronectin accumulation in Pool II (Fig. 4) . Anti-fit Fabs also inhibited initial cell attachment to a fibronectin substratum (Fig. 4) . No changes in cell morphology were detected by phase-contrast microscopy after a 6-h incubation with anti-/3~ Fabs.
Increasing Concentrations of Exogenous Fibronectin Do Not Decrease the Inhibitory Effect of Anti-/~l Fab Fragments
If anti-fit Fabs and exogenous fibronectin were competing for the same binding site, then one might expect increasing concentrations of fibronectin to eventually overcome the anti-/~l Fabs inhibitory effect. Fig. 5 compares binding of fibronectin in Pool I and accumulation of fibronectin in Pool II measured in the absence or presence of anti-fl~ Fabs. Increasing concentrations of exogenous fibronectin up to 30 /xg/ml, a concentration previously shown to occupy >50% of matrix assembly sites (McKeown-Longo and Mosher, 1983) , failed to overcome the inhibitory effect of 5 #g/ml anti-/3~ Fabs. This was true for both fibronectin binding in Pool I and its accumulation in Pool II. Similar results were obtained with anti-/3t IgG (data not shown).
Affinity Chromatography of Extracts of Surface-labeled Cells on Immobilized l~'bronectin 120-kD Cell Attachment Fragment and on Immobilized Fibronectin 70-kD Amino-terminal Fragment
The fact that monoclonal antibodies specific for fl~ and, to a lesser extent, or5 subunits of the fibronectin cell adhesion receptor inhibited 70 kD binding prompted us to examine whether or not ets/3t or another/~l-containing integrin interacts with 70 kD. Detergent extracts of surface-labeled fibroblasts were subjected to affinity chromatography on either immobilized 120-kD cell attachment fragment or immobilized 70 kD. Bound/3~-containing integrin was detected by immunoprecipitation using purified human placental c~fl~ polyclonal antibodies. Immunoblotting studies showed that these antibodies react primarily with the fit subunit (data not shown). Immunoprecipitation of the 120 kD-Sepharose-bound fractions (Fig. 6 , lanes 5 and 6) with rabbit polyclonal antio~5fll showed two iodinated polypeptides migrating at 140 and 120 kD under nonreducing conditions presumably corresponding to the ors and fll subunits of the receptor. When the same volume of labeled cell extract from the same iodinated cell preparation was incubated with 70 kD-Sepharose, no specifically bound ~-containing integrin was detected in either the fractions eluted with 10 mM EDTA (Fig. 6, lanes  11 and 12) or in a subsequent wash of the column with 0.2 M glycine, pH 2.3 (not shown). Similarly, no fl~-containing integrins were detected when placental detergent extracts were chromatographed on 70 kD-Sepharose and then immunoblotted with rabbit polyclonal anti-o~5~ (data not shown).
Discussion
Antibodies to the/~t and, to a lesser extent, or5 subunits of the fibronectin receptor blocked binding of the 70-kD aminoterminal fragment of fibronectin and binding of exogenous plasma fibronectin to monolayers of fibroblasts and its incorporation into extracelhlar matrix. The ability of both IgGs to inhibit fibronectin and 70 kD binding paralleled their ability to inhibit the initial attachment of suspended fibroblasts to a fibronectin substratum. Monovalent Fab fragments of anti-fl~ also inhibited fibronectin and 70 kD binding suggesting that inhibition of ligand binding is not a nonspecific effect due to receptor clustering induced by bivalent IgG.
Anti-/~t IgG (5/zg/ml) blocked FITC-fibronectin binding to cell layers whereas anti-o~5 IgG was much less effective. In contrast, Akiyama et al. (1989) found significant inhibition of extracellular fibronectin matrix accumulation with as little as 1 t~g/ml of anti-ct~ IgG when human embryonic lung fibroblasts (WI38 ceils) were plated in the presence of the antibody and incubated an additional 24 h. The discrepancy may be related to differences in the assay. In the assay described in this paper, we examined the ability of antior5 to block binding of exogenously supplied FITC-fibronectin during a 60-min incubation by using human foreskin fibroblasts that have been allowed to attach and spread in the absence of antibody. Most of the assembly is probably at the ends of already established fibrils (Barry and Mosher, 1989) .
The finding that anti-/~t more effectively inhibited fibro- Figure 4 . Effect of anti-#~ Fab fragments on t25I-fibronectin and ~251-70 kD binding to cell layers and on cell attachment to fibronectin-coated dishes. Confluent monolayers of human fibroblasts were incubated with 0.5 ml Ham's F-12 media containing 10 ttg/ml cycloheximide, 0.2% BSA, and 1251-70 kD (160 rig, 300,000 cpm) or 125I-fibronectin (220 rig, 300,000 cpm) alone or in the presence of increasing concentrations of anti-/~t Fabs for 6 h at 37°C. Binding medium was then removed, and cell layers were washed three times with cold PBS. Cell layers incubated with 1251-70 kD were solubilized in 1 N NaOH, and the radioactivity was counted. Cells incubated with ~25I-fibronectin were extracted in 1% deoxycholate, and the amounts of fibronectin bound in the deoxycholate-soluble Pool I and deoxycholate-insoluble Pool II were determined as described in Materials and Methods. 1251-70 kD binding (open circles) , and ~25I-fibronectin binding in Pool I (open triangles) and Pool II (solid triangles) are expressed as the percent of control binding (see Fig. 1 ). In this experiment, the t251-70 kD control cells bound 2,260 cpm (1.20 rig), and the '25I-fibronectin control cells bound 3,990 cprn (3.0 rig) in Pool I and 1,800 cpm (1.3 rig) in Pool II. Nonspecific binding was measured in the presence of 500/zg/ml unlabeled fibronectin or 25 #g/ml unlabeled 70 kD. nectin and 70 kD binding than did anti-or5 suggested possible involvement of other t~ chains. Antibody blocking and affinity chromatography data suggest that integrin ot3~ is a low affinity receptor for fibronectin and also a receptor for other ligands (Wayner and Carter, 1987; Wayner et al., 1988) . The site on fibronectin that t~3~1 binds is not known though it appears not to bind to 120-kD fibronectin fragment or fibronectin affinity columns at physiological salt concentration (Wayner and Carter, 1987; Hynes et al., 1989; Plantefaber and Hynes, 1989) . Two monoclonal antibodies specific for ot3/~, J143 and P1B5, failed to block fibronectin and 70 kD binding to fibroblast cell layers. Since integrin ~tv, in association with a novel B subunit (fix), has been shown to promote cell attachment to fibronectin in addition to vitronectin (Cheresh et al., 1989) , we examined whether antibodies specific for cry or otvB3 complex inhibited binding of 70 kD. Two monoclonal antibodies, LM142, which is directed to the ct subunit of the vitronectin receptor (Cheresh and Harper, 1987) , and LM609, which is directed to the uv/~3 complex (Cheresh and Spiro, 1987) , also failed to block 70 kD binding to fibroblast cell layers. Studies are ongoing to learn whether other available antiintegrin monoclonal antibodies are inhibitory. Inhibition of fibronectin binding by anti-B~ was demonstrable 20 min after the simultaneous addition of ligand and antibody. This result correlates well with the reported time Roman et al. (1989) found that it took another monoclonal antibody specific for u5/31 (P1F8) to reverse colocalization of the fibronectin receptor with a fibronectin-containing matrix at the immunofluorescence level. In their study fibronectin-o~sB~ interactions were disrupted within 30 min after the addition of P1F8. Figure 6 . Autoradiograph ofiodinated cell surface proteins immunoprecipitated by rabbit anti-txs~t after chromatography on 120 kDor 70 kD-Sepharose. Detergent extracts prepared from surface-labeled human foreskin fibroblasts were subjected to affinity chromatography on either immobilized 120-kD cell attachment fragment or immobilized fibronectin 70-kD amino-terminal fragment. Total cell lysate, unbound fraction and eluted fractions were immunoprecipitated with a polyclonal anti-ctsB~ which recognizes primarily the /~t subunit and immunoprecipitates ~-containing integrins. The immunoprecipitated antigens were fractionated on SDS PAGE (8.0%) under nonreducing conditions. Lane 1, total lysate (starting material); lane 2, 120 kD-Sepharose unbound; lanes 3-7, fractions eluted with 10 mM EDTA from 120 kD-Sepharose; lane 8, 70 kD-Sepharose unbound; lanes 9-12, fractions eluted with 10 mM EDTA from 70 kD-Sepharose. The c~5 and/~ subunits are indicated on the gel by the upper and lower arrowheads, respectively.
Increasing concentrations of exogenous fibronectin were unable to overcome inhibition by anti-B~ Fabs of fibronectin binding. One explanation of this result is that anti-/3~ Fabs have a much higher affinity for the receptor than does fibronectin. A second explanation is that fibronectin and anti-/3~ Fabs do not share the same binding site.
The discovery that a monoclonal antibody to the integrin B~ subunit could block ~2~I-70 kD binding to cell monolayers prompted us to examine whether any Bt-containing integrins bound to the immobilized 70-kD amino-terminal fragment. We were unable, however, to demonstrate binding of a Bt-containing integrin to 70 kD-Sepharose under conditions which resulted in the binding of o~sB~ to immobilized cell adhesion fragment.
We should like to present three possible models to explain the inhibitory effect of the anti-/3~ antibody. (a) c~5/5~ complex binds transiently to the cell adhesive domain of fibronectin causing it to unfold and expose its aminoterminal domain. This initial binding to the cell adhesion domain is rapid but of moderate affinity that has been reported for binding of soluble fibronectin to ceils in suspension (Akiyama and Yamada, 1984) . Such a moderate affinity interaction might explain why no direct binding of iodinated fibronectin cell adhesion fragments could be measured (McKeownLongo and Mosher, 1985) and why large amounts of unlabeled cell adhesion fragments are required to compete fibronectin binding and matrix assembly (McDonald et al., 1987 ; our unpublished resultsg. The anti-Bi would therefore block binding of soluble fibronectin to cell layers and its subsequent incorporation into the matrix by interfering with the initial transient binding event before the unfolding of the amino-terminal 70-kD domain.
After fibronectin unfolds, the amino-terminal domain can bind adjacent cell surface molecules, including adjacent fibronectin molecules. This binding increases the overall affinity of fibronectin binding and allows polymerization to begin. A possible role for fibronectin-fibronectin interactions in fibronectin binding to cell layers is supported by the finding that the amino-terminal region of horse fibronectin contains a self-association site that can interact with the carboxy-terminal regions of another fibronectin molecule in a head-to-tail manner (Ehrismann et al., 1982) . The part of fibronectin mediating this interaction, however, is not in the most amino-terminal part of the protein but instead is probably located in a region spanning the ninth type I homology and the adjacent first type III homology unit (Chernousov, M. A., E J. Fogerty, V. E. Koteliansky, and D. F. Mosher, manuscript in preparation) . This model, furthermore, does not explain how the anti-/3~ can block binding of the isolated 70-kD fragment.
(b) B~ complexed to an undetermined a subunit (Otx) or conformationally changed ~Bm may bind the non-RGDScontaining amino-terminal region (70 kD) of fibronectin to mediate binding of exogenous fibronectin and its incorporation into the matrix. These are reasonable hypotheses to consider. Increasing numbers of integrins are reported to bind other sequences besides or in addition to RGDS. Examples of Bm-containing integrins that bind to their ligands in a RGDS independent manner include VLA3 (c~3~t) binding to fibronectin, collagen, and laminin; VLA1 (ohB~) and VLA2 (a2Bl) binding to type IV and type I collagen, respectively; and VLA4 (O~4~1) binding to fibronectin (Wayner and Carter, 1987; Wayner et al., 1988 Wayner et al., , 1989 Kramer and Marks, 1989) . The hypothesis that a conformationally changed c~/3~ is required to bind the amino-terminal region of fibronectin is also feasible. Platelet glycoprotein 1 lb/11 la is one example of an integrin that must undergo a conformational change before it can bind its ligands (Plow and Ginsberg, 1981) .
Cell attachment and spreading are probably mediated by the actin cytoskeleton that is linked to the integrins (Singer, 1979 (Singer, , 1989 Tamkun et al., 1986; Horwitz et al., 1986; Argraves et al., 1989) . The binding and assembly site for fibronectin is not present on ceils treated with cytochalasin (Barry and Mosher, 1988) . Alterations in the actin cytoskeleton that occur during cell attachment and spreading could potentially alter the conformation of the integrin receptor resulting in exposure of a unique 70-kD binding site. The requirement for a conformationally changed receptor would explain why we were not able to detect binding of detergent solubilized/3~-containing integrin to a 70 kD-Sepharose affinity column.
In this second model anti-/3t could inhibit binding because of steric hindrance if the binding sites for the antibody and ligand were overlapping or adjacent. Alternatively, occupancy of one binding site by anti-/3~ could produce a conformational change in the receptor complex that would then preclude occupancy of the second binding site by the fibronectin or 70-kD fragment (Santoro and Lawing, 1987) .
(c) o~5~ and/or o~x/3~ may recruit a third component to form a binding site with specificity for the 70-kD region. The time that it takes the anti-/3t to uncouple the complex or to interfere with recruitment would explain why the inhibitory effect of anti-B~ lags behind the inhibitory effect of excess fibronectin. Higher concentrations of fibronectin would not be able to overcome the inhibitory effect of the antibody because the antibody and fibronectin are not competing for the same binding site. The identity of the third component and the mechanism of the uncoupling are unknown.
Cross-linking experiments indicate that the assembly of fibronectin is at the ends of growing fibrils (Barry and Mosher, 1989) . One effect of anti-o~5 and -B~ could be dissociation of the fibril ends from assembly sites. Another effect could be to block some modification or rearrangement of preexisting matrix that allows assembly to proceed. The assembly sites seem catalytic, and there must be a mechanism to regenerate the site, such as the endocytic cycle for ~5~ reported by Bretscher (1989) . This mechanism may require cell locomotion. Interference with cycling could explain the peculiar differences in distribution of o~5 and Bt after incubation of fibroblasts with the monoclonal antibodies.
In conclusion, our finding that a monoclonal antibody against the integrin B~ subunit completely blocks binding of the 70-kD amino-terminal fragment of fibronectin indicates that a B,-containing integrin is either directly or peripherally involved in the binding of the aminoterminal "matrix assembly domain" of soluble fibronectin to cell layers. Further studies should elucidate more precisely the role ~ integrins play in fibronectin matrix assembly.
